3-(4-chlorophenyl)-N-[3-(morpholin-4-yl)propyl]-4-oxo-3,4-dihydrophthalazine-1-carboxamide

ID: ALA5178845

PubChem CID: 168276679

Max Phase: Preclinical

Molecular Formula: C22H23ClN4O3

Molecular Weight: 426.90

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(NCCCN1CCOCC1)c1nn(-c2ccc(Cl)cc2)c(=O)c2ccccc12

Standard InChI:  InChI=1S/C22H23ClN4O3/c23-16-6-8-17(9-7-16)27-22(29)19-5-2-1-4-18(19)20(25-27)21(28)24-10-3-11-26-12-14-30-15-13-26/h1-2,4-9H,3,10-15H2,(H,24,28)

Standard InChI Key:  DAMFRSSXKNIFLW-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
   -3.5716   -0.2098    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8570    0.2024    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1452   -0.2094    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1452   -1.0345    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8553   -1.4463    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5716   -1.0382    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4306    0.2031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7161   -0.2094    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7161   -1.0345    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4306   -1.4471    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4306   -2.2722    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0015   -1.4471    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7132   -1.0347    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4253   -1.4467    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4253   -2.2721    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7150   -2.6840    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0015   -2.2758    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1398   -2.6846    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -1.4306    1.0282    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1452    1.4407    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7161    1.4407    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0015    1.0282    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7131    1.4407    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1425    1.4429    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4307    1.0264    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1377    2.2680    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8498    2.6846    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5668    2.2762    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5716    1.4511    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8595    1.0345    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  4  3  2  0
  5  4  1  0
  1  6  1  0
  6  5  2  0
  3  7  1  0
  8  7  2  0
  9  8  1  0
 10  9  1  0
  4 10  1  0
 10 11  2  0
  9 12  1  0
 13 12  2  0
 14 13  1  0
 15 14  2  0
 16 15  1  0
 17 16  2  0
 12 17  1  0
 15 18  1  0
  7 19  1  0
 19 20  2  0
 19 21  1  0
 21 22  1  0
 22 23  1  0
 25 24  1  0
 23 25  1  0
 26 24  1  0
 27 26  1  0
 28 27  1  0
 29 28  1  0
 30 29  1  0
 24 30  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5178845

    ---

Associated Targets(Human)

A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562/A02 (383 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABCB1 Tchem P-glycoprotein 1 (14716 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

MDCK (10148 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 426.90Molecular Weight (Monoisotopic): 426.1459AlogP: 2.49#Rotatable Bonds: 6
Polar Surface Area: 76.46Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.04CX LogP: 2.56CX LogD: 2.40
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.61Np Likeness Score: -2.00

References

1. Shi W, Zhang P, Zou F, Zhou J, Yin Z, Cai Z, Ghaleb H, Jiang Y, Huang W, Liu Y, Qiu Q, Qian H..  (2022)  Exploration of novel phthalazinone derivatives as potential efflux transporter inhibitors for reversing multidrug resistance and improving the oral absorption of paclitaxel.,  233  [PMID:35247755] [10.1016/j.ejmech.2022.114231]

Source